JAU-15280-18339
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 980 / WA
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- U8Z-27969-65434
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Dose 1 — Moderna
-
2022-06-24
Registered in v-safe
-
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
- 2022-06-30
- 2022-07-07
- 2022-07-14
-
2022-07-21
Dose 2 — Moderna
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
-
2022-08-04
Survey response — day 14, dose 2, under 3MedDRA: Asthenia, Decreased appetite, Irritability, Nasal congestion, Pyrexia, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Viral illness: fever, fussiness, low energy, decreased appetite, nasal congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Survey response — day 21, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Clear runny nose left over from last weekMedDRA releases: 2024-11 · check-in free text available
- 2022-08-18
- 2022-08-25
-
2022-09-01
Survey response — day 42, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Clear runny nose, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Respiratory tract congestion — Feeling: GoodFree text: Cough, congestionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-23 | Moderna | No |
| 2 | 2022-07-21 | Moderna | No |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Viral illness: fever, fussiness, low energy, decreased appetite, nasal congestion
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Clear runny nose left over from last week
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Clear runny nose, cough
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Cough, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release